| (INR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 18.00B | — |
| Operating expense | — | — |
| Net income | 3.17B | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, GLAND.NS returned +45.1% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +65.0% |
| 1 year | +45.1% |
| 5 years | -26.1% |
| All-time high | ₹3,930.45 (Jul 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what ₹1,000 in GLAND.NS would be worth today ›Yes. Gland Pharma Limited paid 1 dividend over the past 12 months. The most recent was ₹20.00 per share on Aug 11, 2026. The dividend yield is 0.71%.
Gland Pharma Limited is part of the Healthcare sector.
Gland Pharma Limited has a market cap of 462.17B INR, based on the latest quote.
Gland Pharma Limited is expected to report earnings around Nov 3, 2026. That date is an estimate and has not been confirmed by the company.
